Soybean resistant to both glyphosate and dicamba (Roundup Ready 2 Xtend™) has been developed by Monsanto Inc. and was commercially available for the first time in Canada in 2017. Six field trials were conducted over a 2-yr period (2014–2015) at three locations in southwestern Ontario to determine whether there is a benefit of including dicamba in a postemergence application of glyphosate at two application timings for the control of non-glyphosate-resistant weeds in Roundup Ready 2 Xtend™ soybean. Adding dicamba to glyphosate did not increase control of grass weed species. The tank mix of glyphosate and dicamba increased the control of redroot pigweed, common ragweed, common lambsquarters, and lady’s thumb by as much as 14%, 3%, 7%, and 5%, respectively, at 8 weeks after the late-postemergence application. In general, broadleaf weed density and biomass collected 6 weeks after the late-postemergence application was reduced more with dicamba applied alone or together with glyphosate than when glyphosate was applied alone early postemergence. Due to the absence of a grass herbicide, weed interference with dicamba applied alone resulted in a yield loss of 30%–33% while treatments containing glyphosate resulted in a yield loss of only 3%–7%. The tank mix of glyphosate and dicamba improved broadleaf weed control, but it should not be applied alone due to poor control of grass weeds.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.